1-Azaspiro[3.3]heptane hemioxalate

Catalog No. :
ACTJDL689
CAS No. :
1523571-15-4
Molecular Formula :
C14H24N2O4
Molecular Weight :
284.36

IUPAC Name:1-azaspiro[3.3]heptane hemioxalate

1-Azaspiro[3.3]heptane hemioxalate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$120.00Login to see priceIn stockIn stock
250mg97%$162.00Login to see priceIn stockIn stock
1g97%$365.00Login to see priceIn stockIn stock
5g97%$1094.00Login to see priceIn stockInquiry
25g97%$5306.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Azaspiro[3.3]heptane hemioxalate
IUPAC Name1-azaspiro[3.3]heptane hemioxalate
MDL No.MFCD27988008
Molecular FormulaC14H24N2O4
Molecular Weight284.36
SMILESOC(C(O)=O)=O.C1CC2(CCN2)C1.C3CC4(CCN4)C3
InChI KeyFTMKRJIGDQCVDH-UHFFFAOYSA-N
Synonym1-azaspiro[3.3]heptane hemioxalate | 1523571-15-4 | 1-Azaspiro[3.3]heptane oxalate(2:1) | 1-azaspiro[3.3]heptanehemioxalate | YKC57115 | MFCD27988008 | bis(1-azaspiro[3.3]heptane) oxalate | SB50813 | AS-34440 | CS-0131305 | A926676 | BIS(1-AZASPIRO[3.3]HE
CAS No.1523571-15-4
PubChem CID91663971

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H315-H319-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACTJDL689 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTJDL689 route product structure diagram
    ACTJDL6891523571-15-4 In Stock
Inquiry

2. ACTJDL689 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTJDL689 route product structure diagram
    ACTJDL6891523571-15-4 In Stock
Inquiry

Comments (0)